Targeted degradation of extracellular mitochondrial aspartyl-tRNA synthetase modulates immune responses

The severity of bacterial pneumonia can be worsened by impaired innate immunity resulting in ineffective pathogen clearance. We describe a mitochondrial protein, aspartyl-tRNA synthetase (DARS2), which is released in circulation during bacterial pneumonia in humans and displays intrinsic innate immu...

Full description

Saved in:
Bibliographic Details
Published in:Nature communications Vol. 15; no. 1; pp. 6172 - 16
Main Authors: Johnson, Benjamin S., Farkas, Daniela, El-Mergawy, Rabab, Adair, Jessica A., Elhance, Ajit, Eltobgy, Moemen, Coan, Francesca M., Chafin, Lexie, Joseph, Jessica A., Cornwell, Alex, Johns, Finny J., Rosas, Lorena, Rojas, Mauricio, Farkas, Laszlo, Bednash, Joseph S., Londino, James D., Ray, Prabir, Ray, Anuradha, Kagan, Valerian, Lee, Janet S., Chen, Bill B., Mallampalli, Rama K.
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 22-07-2024
Nature Publishing Group
Nature Portfolio
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The severity of bacterial pneumonia can be worsened by impaired innate immunity resulting in ineffective pathogen clearance. We describe a mitochondrial protein, aspartyl-tRNA synthetase (DARS2), which is released in circulation during bacterial pneumonia in humans and displays intrinsic innate immune properties and cellular repair properties. DARS2 interacts with a bacterial-induced ubiquitin E3 ligase subunit, FBXO24, which targets the synthetase for ubiquitylation and degradation, a process that is inhibited by DARS2 acetylation. During experimental pneumonia, Fbxo24 knockout mice exhibit elevated DARS2 levels with an increase in pulmonary cellular and cytokine levels. In silico modeling identified an FBXO24 inhibitory compound with immunostimulatory properties which extended DARS2 lifespan in cells. Here, we show a unique biological role for an extracellular, mitochondrially derived enzyme and its molecular control by the ubiquitin apparatus, which may serve as a mechanistic platform to enhance protective host immunity through small molecule discovery. Here, Johnson et al show that bacterial pneumonia induces an interaction between the ubiquitin E3 ligase subunit FBX024 and the mitochondrial protein DARS2 to modulate host immune responses.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2041-1723
2041-1723
DOI:10.1038/s41467-024-50031-7